X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

Countdown begins for thailand’s largest medical exhibition as it moves to a new venue in september

Content Team by Content Team
7th August 2019
in Middle East and South Asia, Press Statements
MEDICAL FAIR THAILAND

The 9th edition of MEDICAL FAIR THAILAND makes its move to a new and bigger location at BITEC, Bangkok, from 11 to 13 September. The biennial exhibition will bring together 1,000 exhibitors from 60 countries including 21 national pavilions including for the first time representation from Brazil, Denmark, Hong Kong and Indonesia.

Over three days, more than 10,000 medical and healthcare innovations from around the world serving the hospital, diagnostic, pharmaceutical, and rehabilitation equipment sectors will take centre stage at MEDICAL FAIR THAILAND 2019.

As Thailand’s largest international medical and healthcare exhibition of its kind, MEDICAL FAIR THAILAND is organized by Messe Düsseldorf Asia, and is the ideal sourcing and procurement platform for the industry. Complementing the internationality of the exhibition and the strong sourcing opportunities is the knowledge-sharing and thought leadership focus of the exhibition. This year’s line-up includes events such as the 4th ARTeC conference, WT Wearables Technologies Conference 2019 ASIA, and more.

What’s new: Community Care Pavilion and Start-up Park

  • Community Care Pavilion
    With the ageing population in Southeast Asia expected to make up 15 per cent of its total population by 2035, in Thailand it is estimated the number of individuals aged over 60 will increase to 25 per cent by 2040 and 37 per cent by 2050 – this has given rise to a growing demand for complex and technology-intensive medical interventions and solutions. Making its debut at MEDICAL FAIR THAILAND 2019 is the Community Care Pavilion with companies featuring remote healthcare monitoring solutions, geriatric care, rehabilitation products and assistive devices.

Expect to meet companies from Hong Kong, China, Japan, Taiwan, Singapore and USA, who will showcase products such as: the innovative air mattresses for wound care, an automatic turning bed that can reposition patients, thus reducing care burden of caregivers, a smart diaper solution that helps monitor and gives real-time data and alerts to the caregiver, as well as a fully digitalised innovative healthcare communication system that can help increase efficiency, and many more other products.

  • Start-up Park
    The Start-Up Park is a dedicated showcase for innovative and late stage mature healthcare start-ups to meet industry influencers, angel investors, entrepreneurs to incubators and accelerators. Trade visitors can expect to meet Start-Ups from Singapore, Japan, South Korea, Hong Kong, Taiwan and more

Some of the innovations on show include the Marburg Bone Bank system which is used for the thermal disinfection for bone grafting, an AI software system that helps reduce diagnosis time for sleeping disorders, a one-stop e-platform to locate and book appointments with medical and healthcare professionals and a mobile healthcare app that helps monitor eating habits and help diabetics calculate calories.

Commenting on the relevance of the Start-Up Park at the exhibition, Dr Kakanand Srungboonmee, from the Centre of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, in Bangkok, said:

“It is important to have an event like the Start-Up Park as we need investors who understand the challenges faced by life sciences and medical/ health start-ups. General investors are used to faster development times and seeing quicker returns on their investments in other industry sectors, so when they see the challenges faced by the life sciences and medical/ health sectors such as the longer time needed for development and clinical trials, stricter standards and more restrictive marketing regulations, they are reluctant to invest.”

Complementing the Start-up Park is the Start-up Podium® – a comprehensive programme that includes a series of fireside chats and panel discussions with industry leaders and experts in their field; topics include Remote Diabetes Monitoring Application, Challenges Facing MedTech companies: A Regional Perspective, Women in Medtech and Life sciences, to the Role of management graduates in healthcare Start-Ups.

Industry-led conferences and concurrent events

  • 4th Advanced Rehab Technology Conference (ARTeC): 11 & 12 September

Jointly organized by The Royal College of Physiatrists of Thailand, Thai Rehabilitation Medicine Association and Messe Düsseldorf Asia, this edition will focus on the theme – The combination of Ultrasonography and Electrodiagnosis: An innovative approach to neuromuscular disorders. The two day conference includes renowned industry-thought leaders from Canada, USA and Thailand, and will offer insights into specialist topics such as Ultrasound evaluation of Peripheral Nerve and Focal Neuropathies, Normal Neuromuscular Ultrasound, and many more.

  • WT Wearable Technologies Conference 2019 ASIA: 11 September

The 35th edition of this conference will provide networking opportunities and insight into how wearables are digitalising the healthcare industry, as well as uncover a new era of fitness wearables and the latest enabling technologies in this extravagant line-up that discusses everything from latest generation rechargeable microcells, adaptive analytics, to infrastructure for precision medicine and connected healthcare platforms.

  • Nursing and Health Literacy for Non-Communicable Disease (NCD) Management: 12 & 13 September

With chronic diseases – particularly NCDs being a problem to health and at the same time, threatening the health care system; nursing professionals will have a greater role and involvement in helping to solve NCDs – helping to promote and prevent NCDs at healthcare facilities and also as advocates to promote healthcare. The two-day conference organized by the Thai Nurses Association will cover topics such as Policy and Strategy on Prevention and Control of NCDs, Service delivery of health care system for NCDs: The Challenges of an ageing Population, Concept and Experience using alternative medicine in NCD practice, and more.

As the region’s largest international medical and healthcare exhibition, MEDICAL FAIR THAILAND 2019 is a must-visit business platform and will continue to set the stage for the industry, as it shares in the expertise of MEDICA – the world’s No.1 medical exhibition and MEDICAlliance, the global portfolio of medical exhibitions under the Messe Düsseldorf group in Germany.

For more information on MEDICAL FAIR THAILAND 2019 and to register your visit, go to: www.medicalfair-thailand.com

 

Previous Post

Lonza Partners with Vineti Across its Cell and Gene Therapy Manufacturing Network to Optimize Vein to Vein Delivery Service

Next Post

GSK grants exclusive technology license for clinical stage Ebola vaccines to Sabin Vaccine Institute

Related Posts

Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Next Post
GSK Ebola Zaire

GSK grants exclusive technology license for clinical stage Ebola vaccines to Sabin Vaccine Institute

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In